Skip to main content
Equibles
AVTR logo

AVTR · Avantor, Inc. · Metrics

Track AVTR — free

Use AVTR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AVTR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.54 -0.08 (-0.51%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$10.53B
Shares
677.62M
Volume · Nov 13 6.82M Avg daily vol (3M) 8.59M

AVTR metrics

104 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$15.54
Market cap
$10.53B

Price action

23 metrics
Price change (1W)
+0.5%
Price change (30D)
-3.4%
Price change (3M)
+13.8%
Price change (6M)
+103.9%
Price change (YTD)
+35.6%
Price change (1Y)
+32.8%
Trailing year
Price change (5Y)
-59.1%
52-week high
$17.29
52-week low
$7.41
Change from 52-week high
-10.1%
Change from 52-week low
+109.7%
Annualized volatility
43.4%
Annualized volatility (3M)
30.7%
Implied volatility (30D)
43.4%
IV rank (1Y)
22.9
IV percentile (1Y)
25.8
Beta
0.9
RSI (14D)
45.3
Price vs SMA 50
-1.0%
Price vs SMA 200
+36.5%
Avg volume (3M)
8.59M
Relative volume
0.8
Average dollar volume
$133.75M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
677.62M

Valuation

12 metrics
P / E (TTM)
31.1
Trailing earnings · reciprocal yield 3.2%
PEG ratio
—
EV / revenue
2.1×
reciprocal yield 48.3%
EV / EBITDA
15.2×
reciprocal yield 6.6%
EV / EBIT
28.2×
reciprocal yield 3.5%
P / sales
1.6×
reciprocal yield 63.0%
P / book
1.8
reciprocal yield 55.4%
FCF yield
4.2%
TTM · current market cap
Buyback yield
—
P / FCF
24.0
reciprocal yield 4.2%
P / operating cash flow
18.0
reciprocal yield 5.6%
Earnings yield
3.2%

Historical valuation

8 metrics
P / E historical average (3Y)
36.1×
reciprocal yield 2.8%
P / E historical average (5Y)
34.4×
reciprocal yield 2.9%
EV / revenue historical average (3Y)
2.3×
reciprocal yield 43.8%
EV / revenue historical average (5Y)
2.6×
reciprocal yield 37.9%
EV / EBIT historical average (3Y)
26.7×
reciprocal yield 3.7%
EV / EBIT historical average (5Y)
25.1×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
32.3×
reciprocal yield 3.1%
EV / EBITDA historical average (5Y)
25.6×
reciprocal yield 3.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
31.6%
Operating margin
7.3%
Trailing 12 months
Net margin
5.1%
Gross profit (TTM)
$2.10B
Operating profit (TTM)
$487.20M
Net income (TTM)
$337.20M
Trailing 12 months
Diluted EPS (TTM)
$0.50
FCF margin
6.6%
Effective tax rate
-6.9%

Per share

11 metrics
Revenue per diluted share (TTM)
$9.79
Gross profit per diluted share (TTM)
$3.09
Operating profit per diluted share (TTM)
$0.72
EBITDA per diluted share (TTM)
$1.34
Net income per diluted share (TTM)
$0.50
Operating cash flow per diluted share (TTM)
$0.86
Free cash flow per diluted share (TTM)
$0.65
Capital expenditures per diluted share (TTM)
$0.21
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.07
Book value per share
$8.16

Growth

11 metrics
Revenue growth YoY
+4.6%
Year over year
Net income growth YoY
-174.5%
Revenue (TTM)
$6.64B
Trailing 12 months
EPS growth YoY
-175.0%
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.5%
Revenue CAGR (5Y)
+0.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-11.3%
FCF CAGR (5Y)
-10.6%

Quality

14 metrics
Return on equity
5.8%
Return on assets
2.9%
Debt / equity
0.6
Current ratio
1.9
EBITDA (TTM)
$906.40M
Free cash flow (TTM)
$439.20M
Quick ratio
1.3
Interest coverage
3.0
Net debt / EBITDA
3.6
Return on invested capital
—
Trailing 12 months
Net cash
−$3.22B
Latest balance sheet
Cash & equivalents
$464.30M
Total assets
$11.63B
Total debt
$3.68B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$584.70M
Capital expenditures (TTM)
$145.50M
R&D (TTM)
—
SG&A (TTM)
$1.60B
Stock compensation (TTM)
$47.80M
R&D / revenue
—
Stock compensation / revenue
0.7%

Ownership (13F)

9 metrics
13F filers
461
13F filer change QoQ
+27
Institutional ownership
103.3%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.0%
Holder tenure
12.5
Price vs estimated holder cost
-33.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
19.0%

Short interest

3 metrics
Short interest
4.0%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1722482 CUSIP 05352A100 13F (30d) 397 filings 366 filers Visit website Investor relations